Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach

  • Hester Lieng Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network Department of Radiation Oncology, University of Toronto
  • Padraig Warde Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network Department of Radiation Oncology, University of Toronto
  • Philippe Bedard Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, Department of Medicine, University of Toronto
  • Robert J. Hamilton Department of Surgery (Urology) and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto
  • Aaron R. Hansen Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, Department of Medicine, University of Toronto
  • Michael A. S. Jewett Department of Surgery (Urology) and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto
  • Martin O'Malley Division of Abdominal Imaging, Joint Department of Medical Imaging, University of Toronto
  • Joan Sweet Department of Pathology and Lab Medicine, University Health Network, University of Toronto
  • Peter Chung Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network Department of Radiation Oncology, University of Toronto

Abstract

Testicular seminoma most commonly affects young men and is associated with favourable prognosis. Various followup schedules and imaging protocols for testicular seminoma have been described without overall consensus. We reviewed the literature together with our experience at the Princess Margaret Cancer Centre and present an evidence-based followup approach for patients with stage I and II seminoma.
Published
2017-12-01
How to Cite
Lieng, H., Warde, P., Bedard, P., Hamilton, R. J., Hansen, A. R., Jewett, M. A. S., O’Malley, M., Sweet, J., & Chung, P. (2017). Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach. Canadian Urological Association Journal, 12(2), 59-66. https://doi.org/10.5489/cuaj.4531